Your body is changing, clothes fit differently and stories about weight injections seem to appear everywhere. It is easy to assume there must be a treatment specifically for a “menopause belly”. In practice, menopause symptoms and a medical reason for weight treatment need separate assessment before they can be brought together in one useful care plan.
Health information for general guidance. This content provides general information. It does not replace medical advice, examination, diagnosis or treatment, or individual nutrition advice. Discuss medication decisions with your treating clinician; do not change treatment based on this page. Seek medical help for acute or severe symptoms.
Take changes seriously without giving everything one explanation
Sleep, mood, menstrual patterns and body shape may change around menopause. Several changes at once can make everyday life difficult. A single explanation will not necessarily account for all of them. Write down what started first, what limits you most and whether the change was sudden or gradual. This also leaves room to consider other possible causes during your appointment.
What an authorisation actually covers
Wegovy is authorised in the EU for weight management under specified conditions. Assessment includes weight category, related health conditions and individual benefits and risks. Menopause is not a separate indication. Marketing aimed at a particular stage of life cannot replace that assessment. Other products may have different authorised uses, so the broad label “weight injection” is not precise enough for a treatment decision.
What hormone therapy research cannot yet tell us
A small retrospective study compared 16 postmenopausal women using hormone therapy with 90 not using it during semaglutide treatment. Different weight outcomes do not prove an added hormone therapy effect: treatment was not randomly assigned.
A useful question is what this finding can actually tell you about your circumstances. It is not a reason to start hormone therapy simply to increase weight loss. Nor can a headline about an average predict how an individual person will respond. Understanding uncertainty helps you keep expectations realistic without dismissing your concerns.
Bring two concerns into one plan
Night sweats and exhaustion may be your main problems, with little concern about the scale. Alternatively, joint discomfort or a diagnosed condition may matter most. State that priority clearly. A shared plan can identify which symptoms need a gynaecological assessment, who would supervise any weight treatment and when the different parts of care will be reviewed together.
Look beyond a single number
Choose two or three everyday observations: how rested do you feel in the morning? Are stairs or shopping easier? Can you eat regularly without food thoughts dominating the day? These notes complement medical measurements. If treatment changes your weight but also leaves you noticeably weaker or persistently unwell, raise this early. A smaller number is not a complete assessment of benefit.
An appointment without having to justify your body
Bring your medication list, previous treatment experiences and your main questions. You do not need to defend your shape or arrive asking for a prescription. Ask about alternatives, the expected benefit and support if adverse effects occur. Agree how you will recognise that a plan needs review. It is reasonable for a decision to take more than one conversation.
How to get started
- Write down your three main concerns separately from weight.
- Bring a complete medication list, including any hormone therapy.
- Agree practical goals and a coordinated follow-up appointment.
Common questions
Do weight medicines treat hot flushes?
The authorisations discussed here concern weight management. They do not establish a targeted treatment for hot flushes. Raise troublesome menopause symptoms as a concern in their own right.
Does a changing waist show that I have a hormone deficiency?
No. Body shape alone is not a diagnosis. Your symptoms, their timing and your medical circumstances help guide an appropriate assessment.
Sources & further reading
- NHS: Menopause and perimenopause – symptoms
- Hurtado et al. (2024): Semaglutide and hormone therapy – observational cohort
- EMA: Wegovy – European public assessment report
Sources checked:





Questions and experiences
Share a question or a useful experience about this topic. Every contribution is checked before publication. Comments may be written in different languages.
Loading reader contributions…
Opening the form sets a necessary session cookie. No email address is required. Publication is subject to moderation and is not guaranteed. For deletion requests: Contact